NGNE
#2634
Neurogene Inc. - Common Stock
38.5 5 USD
+0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.80%
Variación mensual
+15.01%
Variación en los últimos 6 meses
+91.89%
Cambio anual
+31.03%
Cierres anteriores
37.8 7
Open
39.0 9
Mínimo
38.5 5
Máximo
39.7 2
Volumen
51
Financials
- Market Capitalization 771.44 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.25
Relación precio/flujo de caja
2 346.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2624 |  AURA Aura Biosciences, Inc. - Common Stock | 7.55 USD | +1.62% | -1.44% | +7.70% | +19.84% | 782.97 M USD | ||
| 2632 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.47 USD | +0.85% | +10.12% | +8.23% | -19.68% | 766.13 M USD | ||
| 2639 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 23.91 USD | +3.69% | -1.24% | +10.85% | +274.76% | 779.02 M USD | ||
| 2668 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.54 USD | +1.08% | -3.96% | +12.76% | -20.82% | 729.27 M USD |